Genoa Ventures invests in early-stage companies innovating at the convergence of biology and technology.
Visionary startups developing innovative life science technologies with outsized potential often struggle to raise capital from traditional funders. These companies are typically multi-disciplinary (e.g. genomics + optics + microfluidics + big data) and/or market-making, and don't neatly fit most VC’s patterns and boxes.
Genoa Ventures stands in this gap. Genoa Ventures uniquely combines an appetite for technology-driven, “category-defying” opportunities in life sciences with the domain expertise and operational experience necessary to select and nurture the best bio-based companies early, before most other investors. We take the time to understand the science and technology, applications and markets, and to help these companies achieve their full potential.
We believe in the enormous and relatively untapped possibilities of life science technologies and discoveries applied to realms outside of healthcare, and in the unbounded potential of the entrepreneurial visionaries who will lead us in realizing these possibilities.
Genoa Ventures is the new name for 5 Prime Ventures.
Visionary startups developing innovative life science technologies with outsized potential often struggle to raise capital from traditional funders. These companies are typically multi-disciplinary (e.g. genomics + optics + microfluidics + big data) and/or market-making, and don't neatly fit most VC’s patterns and boxes.
Genoa Ventures stands in this gap. Genoa Ventures uniquely combines an appetite for technology-driven, “category-defying” opportunities in life sciences with the domain expertise and operational experience necessary to select and nurture the best bio-based companies early, before most other investors. We take the time to understand the science and technology, applications and markets, and to help these companies achieve their full potential.
We believe in the enormous and relatively untapped possibilities of life science technologies and discoveries applied to realms outside of healthcare, and in the unbounded potential of the entrepreneurial visionaries who will lead us in realizing these possibilities.
Genoa Ventures is the new name for 5 Prime Ventures.
Location: United States, California, San Francisco
Employees: 1-10
Founded date: 2018
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 24
| Date | Name | Website | Total Raised | Location |
| 08.09.2022 | Bond Pet F... | bondpets.com | $18.95M | United Sta... |
| 23.02.2022 | SCIEX | sciex.com | - | Canada, On... |
| 23.02.2022 | Epitel | epitel.com | $12.5M | United Sta... |
| 23.02.2022 | Home | reduxbio.com | - | - |
| 21.07.2021 | Stemson Th... | stemsontx.com | $22.79M | United Sta... |
| 21.07.2021 | SimBioSys | simbiosys.com | $15M | - |
| 21.07.2021 | Meiogenix | meiogenix.com | $13M | - |
| 21.07.2021 | Attune Neu... | attuneneuro.com | - | - |
| 21.07.2021 | .. | bloodq.com | - | - |
| 10.02.2021 | Adarza Bio... | adarzabio.com | $28.8M | United Sta... |
Show more
Persons 12
| Date | First Name | Last Name | Title | Location | |||
| - | Rebecca M. | Galler | Chief Mark... | linkedin.c... | - | r*****a@ge... | - |
| - | Landon | Merrill | - | linkedin.c... | - | l****n@gen... | - |
| - | Amy | Harris | VP of Fina... | linkedin.c... | - | A*y@genoav... | - |
| - | Vatshal | Bhanushali | Venture As... | linkedin.c... | - | v*****l@ge... | - |
| - | Vikram | Chaudhery | - | linkedin.c... | - | v****m@gen... | - |
| - | Negin | Mokhtari, ... | Senior Ass... | linkedin.c... | - | n***n@geno... | - |
| - | Tony | Day | Venture Pa... | linkedin.c... | - | t**y@genoa... | - |
| - | Paco | Cifuentes | Venture Pa... | linkedin.c... | - | p**o@genoa... | - |
| - | Erik | Gentalen | Entreprene... | linkedin.c... | - | E**k@genoa... | - |
| - | William (B... | Hyun | Venture Pa... | linkedin.c... | - | b**l@genoa... | - |
Show more
Mentions in press and media 13
| Date | Title | Description |
| 11.07.2024 | BrightSpec Adds Commercial Firepower to its Leadership Team and Board of Directors | Industry vets Damien Fischer and Tim Germann bring decades of market experience in the life sciences and analytical tools CHARLOTTESVILLE, Va. and WALTHAM, Mass., July 11, 2024 /PRNewswire/ -- BrightSpec, the market leader in Molecular Rota... |
| 12.06.2024 | Alida Biosciences Pioneers Epitranscriptomic Research with $7.5M Series A Funding | Alida Biosciences, a cutting-edge biotech company based in San Diego, has recently made waves in the scientific community by securing a substantial $7.5 million in Series A funding. Spearheaded by the visionary leadership of Dr. Gudrun Sten... |
| 12.06.2024 | AlidaBio Secures $7.5M to Optimize Epitranscriptomic Research | What You Should Know: – Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation fr... |
| 20.05.2024 | SynBioBeta 2024: From novel hosts to ‘tricking’ cells to be more productive… addressing the ‘scale-cost paradox’ in biomanufacturing | Since insulin produced by genetically engineered bacteria—rather than the pancreases of slaughtered animals—was first approved in 1982, the market for ‘biomanufactured’ products produced by microbial, animal, or plant cells has grown rapidl... |
| 24.04.2024 | Wilbur-Ellis Nutrition shakes on strategic partnership with Bond Pet Foods | ST. JOSEPH, MO. and BOULDER, COLO. — Following a major milestone in its partnership with Hill’s Pet Nutrition earlier this year, Bond Pet Foods announced April 23 it has teamed up with Wilbur-Ellis Nutrition, LLC, to develop sustainable pet... |
| 15.01.2023 | 11 podcasts that busy venture capitalists and founders say they trust right now | Investors at JetBlue Ventures, Mighty Capital, and other VC firms shared their favorite podcasts. They include "All-In" with Chamath Palihapitiya and "The Future of Everything" by the WSJ. Advertisement Global venture-ca... |
| 15.01.2023 | 11 podcasts that busy venture capitalists and founders say they trust right now | Chamath Palihapitiya cohosts the podcast "All-In." Brian Ach/Getty Images Investors at JetBlue Ventures, Mighty Capital, and other VC firms shared their favorite podcasts. They include "All-In" with Chamath Palihapitiya ... |
| 19.08.2022 | Meet Jenny Rooke, founder and Managing Partner at Genoa Ventures | Genoa Ventures invests at the intersection of biology and technology Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more startups than ... |
| 29.07.2022 | Genoa Ventures Closes Second Fund, at $84M | Genoa Ventures, a San Francisco, CA-based venture firm investing in the convergence of biology and technology, closed its second fund, at $84 million. Genoa Ventures Fund II will continue Genoa’s investing focus on startups innovating in ma... |
| 28.07.2022 | Instacart’s comedown speaks volumes about the plight of digital retail | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The summer of 2022 is proving to be a long and lonely one for digital retail. Paid Content Migrat... |
Show more